AVEO Oncology
AVEO
#7150
Rank
HK$4.07 B
Marketcap
HK$117.20
Share price
0.00%
Change (1 day)
172.28%
Change (1 year)

AVEO Oncology (AVEO) - Total debt

Total debt on the balance sheet as of September 2022 : HK$0.30 Billion

According to AVEO Oncology 's latest financial reports the company's total debt is HK$0.30 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

AVEO Oncology - Total debt on balance sheet (from 2008 to 2022)

Total debt by year

Year Total debt Change
2021-12-31HK$0.29 B163.82%
2020-12-31HK$0.11 B-8.6%
2019-12-31HK$0.12 B-17.62%
2018-12-31HK$0.14 B3.25%
2017-12-31HK$0.14 B32.94%
2016-12-31HK$0.10 B47.92%
2015-12-31HK$73.4 M-54.17%
2014-12-31HK$0.16 B7.56%
2013-12-31HK$0.14 B-26.21%
2012-12-31HK$0.20 B7.51%
2011-12-31HK$0.18 B3.08%
2010-12-31HK$0.18 B18.96%
2009-12-31HK$0.15 B-5.91%
2008-12-31HK$0.16 B38.4%
2007-12-31HK$0.11 B

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Eli Lilly
LLY
HK$332.08 B 109,783.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$426.50 B 141,024.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
HK$51.38 B 16,904.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
HK$21.14 B 6,895.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$368.31 B 121,769.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Merrimack Pharmaceuticals
MACK
HK$0.12 B-57.09%๐Ÿ‡บ๐Ÿ‡ธ USA